Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 25014355)


Unzipping androgen action through ZIP9: a novel membrane androgen receptor.

Pascal LE, Wang Z.

Endocrinology. 2014 Nov;155(11):4120-3. doi: 10.1210/en.2014-1749. No abstract available.


Essential role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in B-cell receptor signaling pathway in DT40 cells.

Taniguchi M, Fukunaka A, Hagihara M, Watanabe K, Kamino S, Kambe T, Enomoto S, Hiromura M.

PLoS One. 2013;8(3):e58022. doi: 10.1371/journal.pone.0058022. Epub 2013 Mar 7.


Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone.

Costello LC, Liu Y, Zou J, Franklin RB.

J Biol Chem. 1999 Jun 18;274(25):17499-504.


The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells.

Ku JH, Seo SY, Kwak C, Kim HH.

Urol Oncol. 2012 Sep;30(5):562-8. doi: 10.1016/j.urolonc.2010.06.001. Epub 2010 Sep 6.


SLC39A9 (ZIP9) regulates zinc homeostasis in the secretory pathway: characterization of the ZIP subfamily I protein in vertebrate cells.

Matsuura W, Yamazaki T, Yamaguchi-Iwai Y, Masuda S, Nagao M, Andrews GK, Kambe T.

Biosci Biotechnol Biochem. 2009 May;73(5):1142-8. Epub 2009 May 7.


Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells.

Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, Konstantinidis G, Föller M, Gravanis A, Alevizopoulos K, Lang F, Stournaras C.

Mol Cancer. 2008 Dec 3;7:88. doi: 10.1186/1476-4598-7-88.


Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells.

Chang GT, Steenbeek M, Schippers E, Blok LJ, van Weerden WM, van Alewijk DC, Eussen BH, van Steenbrugge GJ, Brinkmann AO.

J Natl Cancer Inst. 2000 Sep 6;92(17):1414-21.


[The regulation of the activation in BCR signaling by ZIP9 transporter].

Taniguchi M, Enomoto S, Hiromura M.

Yakugaku Zasshi. 2014;134(7):809-12. Review. Japanese.


Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.

Gründker C, Föst C, Fister S, Nolte N, Günthert AR, Emons G.

Breast Cancer Res. 2010;12(4):R49. doi: 10.1186/bcr2606. Epub 2010 Jul 14.


Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.

Dai JL, Maiorino CA, Gkonos PJ, Burnstein KL.

Steroids. 1996 Sep;61(9):531-9.


Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.

Rokhlin OW, Glover RB, Guseva NV, Taghiyev AF, Kohlgraf KG, Cohen MB.

Mol Cancer Res. 2006 Feb;4(2):113-23.


Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling.

Kawamura S, Sato I, Wada T, Yamaguchi K, Li Y, Li D, Zhao X, Ueno S, Aoki H, Tochigi T, Kuwahara M, Kitamura T, Takahashi K, Moriya S, Miyagi T.

Cell Death Differ. 2012 Jan;19(1):170-9. doi: 10.1038/cdd.2011.83. Epub 2011 Jun 17.


Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo.

Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C, Gravanis A, Castanas E.

J Clin Endocrinol Metab. 2005 Feb;90(2):893-903. Epub 2004 Dec 7.


Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.

Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ.

Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk